<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Medical Microscopes</title>
	<atom:link href="http://www.medicalmicroscopes.net/WP/feed" rel="self" type="application/rss+xml" />
	<link>http://medicalmicroscopes.net/WP</link>
	<description>all about medical microscopes</description>
	<pubDate>Tue, 21 Aug 2007 02:37:07 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
	<language>en</language>
			<item>
		<title>Sarcoma Of the Esophagus</title>
		<link>http://medicalmicroscopes.net/WP/archives/10</link>
		<comments>http://medicalmicroscopes.net/WP/archives/10#comments</comments>
		<pubDate>Tue, 17 Jul 2007 04:00:54 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/sarcoma-of-the-

esophagus/</guid>
		<description><![CDATA[Sarcomas and carcinosarcomas are 
rare tumors that can be seen using medical microscopes, accounting for approximately 0.1 to 1.5% of all esophageal 
tumors. They present with the symptom of dysphagia, which does not differ from the dysphagia associated with the 
more common epithelial carcinoma. Tumors located within the cervical or high thoracic esophagus can cause [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoBodyText">Sarcomas and carcinosarcomas are </p>
<p>rare tumors that can be seen using medical microscopes, accounting for approximately 0.1 to 1.5% of all esophageal </p>
<p>tumors. They present with the symptom of dysphagia, which does not differ from the dysphagia associated with the </p>
<p>more common epithelial carcinoma. Tumors located within the cervical or high thoracic esophagus can cause symptoms </p>
<p>of pulmonary aspiration secondary to esophageal obstruction. Large tumors originating at the level of the tracheal </p>
<p>bifurcation can produce symptoms of airway obstruction and synÂ­cope by direct compression of the tracheobronchial </p>
<p>tree and heart. The duration of dysphagia and age of the patients afÂ­fected with these tumors are similar to those </p>
<p>with carcinoma of the esophagus.<span id="more-10"></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial">A barium swallow usually shows a large polypoid </p>
<p>intialuminal esophageal mass, causing partial obstruction and dilatation of the esophagus proximal to the tumor. </p>
<p>The smooth polypoid nature of the lesion, seen through a medical microscope, although not diagnostic, is </p>
<p>distinctive enough to suggest the presence of a sarcoma rather than the more common ulcerating, stenosing </p>
<p>carcinoma.</span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-</p>
<p>family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: </p>
<p>10pt; font-family: Arial">Esophagoscopy commonly shows an intraluminal necrotic mass. When biopsy is attempted and </p>
<p>the tissue examined under a medical microscope, it is important to remove the necrotic tisÂ­sue until bleeding is </p>
<p>seen on the tumor&#8217;s surface. When this is not done, the biopsy specimen will show only tissue necrosis when it is </p>
<p>examined under a microscope. Even when viable tumor is obtained on biopsy, it has been observed that it cannot be </p>
<p>definitively identified as carcinoma, sarÂ­coma, or carcinosarcoma on the basis of the histology of the portion </p>
<p>biopsied. Biopsy results cannot be totally relied on to identify the presence of sarcoma, and it is often the </p>
<p>polypoid nature of the leÂ­sion, which arouses suspicion that it may be something other than </p>
<p>carcinoma.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; </p>
<p>font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-</p>
<p>size: 10pt; font-family: Arial">Polypoid sarcomas of the esophagus, in contrast to infiltrating carcinomas, remain </p>
<p>superficial to the muscularis propria and are less likely to metastasize to regional lymph nodes. In one series of </p>
<p>14 patients, local extension or tumor metastasis would have preÂ­vented a potentially curative resection in only </p>
<p>five. Thus the presÂ­ence of a large polypoid tumor should not deter the surgeon from resecting the </p>
<p>lesion.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; </p>
<p>font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-</p>
<p>size: 10pt; font-family: Arial">Sarcomatous lesions of the esophagus can be divided into epiÂ­dermoid carcinomas </p>
<p>with spindle cell features, such as carcinosarÂ­coma, and true sarcomas that arise from mesenchymal tissue, such as </p>
<p>leiomyosarcoma, fibrosarcoma, and rhabdomyosarcoma. Based on current histologic criteria for diagnosis, </p>
<p>fibrosarcoma and rhabÂ­domyosarcoma of the esophagus are extremely rare lesions and may not in fact </p>
<p>exist.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; </p>
<p>font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-</p>
<p>size: 10pt; font-family: Arial">Surgical resection of polypoid sarcoma of the esophagus is the treatment of choice, </p>
<p>since radiation therapy has little success and the tumor remain superficial, with local invasion or distant </p>
<p>metastases occurring late in the course of the disease. As with carcinoma, the absence of both wall penetration and </p>
<p>lymph node metastases is necÂ­essary for curative treatment. Surgical resection is consequently responsible for the </p>
<p>majority of the reported 5-year survivals. ReÂ­section also provides an excellent means of alleviating the </p>
<p>patient&#8217;s symptoms. The surgical technique for resection and the subsequent restoration of the gastrointestinal </p>
<p>continuity is similar to that deÂ­scribed for carcinoma.<o:p></o:p></span></p>
<p class="MsoNormal" style="text</p>
<p>-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">It was observed that four of the </p>
<p>eight patients with carciÂ­nosarcoma survived for 5 years or longer. Even though this number is small, it suggests </p>
<p>that resection produces better results in epÂ­ithelial carcinoma with spindle cell features than in squamous cell </p>
<p>carcinoma of the esophagus. Similarly, with leiomyosarcoma of the esophagus, the same scattered reports exist with </p>
<p>little information on survival. Of seven patients with leimyosarcoma, two died from their disease-one in 3 months </p>
<p>and the other 4 years and 7 months after resection. The other five patients were reported to have survived more </p>
<p>than 5 years.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: </p>
<p>10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial">It is difficult to evaluate the benefits of resection for leiomyoÂ­</p>
<p>blastoma of the esophagus, due to the small number of reported patients with tumors in this location. Most </p>
<p>leiomyoblastomas occur in the stomach, and 38% of these patients succumb to the cancer in 3 years. Fifty-five </p>
<p>percent of patients with extragastric leiomyÂ­oblastoma also die from the disease, within an average of 3 years. </p>
<p>Consequently, leiomyoblastoma should be considered a malignant lesion and apt to behave like a leiomyosarcoma. The </p>
<p>presence of nuclear hyperchromatism, increased mitotic figures, tumor size larger than 10 cm, and clinical symptoms </p>
<p>of longer than 6 months&#8217; duration are associated with a poor prognosis.<o:p></o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </p>
<p></o:p></span></p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/10/feed</wfw:commentRss>
		</item>
		<item>
		<title>Benign Tumors and Cysts</title>
		<link>http://medicalmicroscopes.net/WP/archives/9</link>
		<comments>http://medicalmicroscopes.net/WP/archives/9#comments</comments>
		<pubDate>Tue, 17 Jul 2007 03:59:07 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/benign-tumors-and-cysts/</guid>
		<description><![CDATA[Benign tumors and cysts of the esophagus are relatively uncommon and 
can be studied using medical microscopes. From the perspectives of both the clinician and the pathologist using a 
medical microscope, benign tumors may be divided into those that are within the muscular wall and those that are 
within the lumen of the esophagus.
 
Intramural [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial">Benign tumors and cysts of the esophagus are relatively uncommon and </p>
<p>can be studied using medical microscopes. From the perspectives of both the clinician and the pathologist using a </p>
<p>medical microscope, benign tumors may be divided into those that are within the muscular wall and those that are </p>
<p>within the lumen of the esophagus.</span><span id="more-9"></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial">Intramural lesions are either solid tumors or cysts, and </p>
<p>the vast majority are leiomyomas. These lesions are made up of varying portions of smooth muscle and fibrous tissue </p>
<p>which can be directly observed under a medical microscope. Fibromas, myomas, fibromyÂ­omas, and lipomyomas are </p>
<p>closely related and occur rarely. Other histologic types of solid intramural tumors have been described, such as </p>
<p>lipomas, neurofibromas, hemangiomas, osteochondromas, granular cell myoblastomas, and glomus tumors, but they are </p>
<p>medÂ­ical curiosities.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font</p>
<p>-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial">Intraluminal lesions are polypoid or pedunculated growths that usually </p>
<p>originate in the submucosa, develop mainly into the lumen, and are covered with normal stratified squamous </p>
<p>epithelium when examined under medical microscopes. The majority of these tumors are composed of fibrous tissue of </p>
<p>varyÂ­ing degrees of compactness with a rich vascular supply. Some are loose and myxoid like myxomas and </p>
<p>myxofibromas, some are more collagenous like fibromas, and some contain adipose tissue such as fibrolipomas. These </p>
<p>different types of tumor, usually studied under medical microscopes, are frequently collecÂ­tively designated as </p>
<p>fibrovascular polyps, or simply as polyps. PeÂ­dunculated intraluminal tumors should be removed. If the lesion is </p>
<p>not too large, endoscopic removal with a snare is feasible.<o:p></o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><strong><span style="font-size: 10pt; font-family: Arial"><o:p> </p>
<p></o:p></span></strong></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: </p>
<p>10pt; font-family: Arial">Leiomyoma<o:p></o:p></span></strong></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Leiomyomas constitute more than 50% </p>
<p>of benign esophageal tuÂ­mors. The average age at presentation is 38 years, which is in sharp conÂ­trast to that </p>
<p>seen with esophageal carcinoma. Leiomyomas are twice as common in males. Since these tumors originate in the smooth </p>
<p>muscle, 90% are located in the lower two thirds of the esophagus. They are usuÂ­ally solitary, but multiple tumors </p>
<p>have been found on occasion with the use of specialized medical microscopes. They vary greatly in size and shape. </p>
<p>Tumors as small as 1 cm in diameter and as large as 10 lb have been removed.<o:p></o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </p>
<p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: </p>
<p>Arial">Typically, leiomyomas are oval. During their growth, they remain intramural, having the bulk of their mass </p>
<p>protruding toward the outer wall of the esophagus. The overlying mucosa is freely movable and normal in appearance. </p>
<p>Neither their size nor location correlates with the degree of symptoms. Dysphagia and pain are the most common </p>
<p>complaints, the two symptoms occurring more frequently together than separately. Bleeding directly related to the </p>
<p>tumor is rare, and when vomiting blood or having blood tarry stools occurs in a patient with an esophageal </p>
<p>leiomyoma, other causes should be investigated.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">A barium swallow is the most useful </p>
<p>method to demonstrate a Leiomyoma of the esophagus. In profile, the tumor appears as a smooth, crescent-shaped </p>
<p>filling defect that moves with swallowing, is sharply demarcated, and is covered and surrounded by normal mucosa. </p>
<p>Esophagoscopy should be performed to exclude the reported observation of a coexistence with carcinoma. The freely </p>
<p>movable mass, which bulges into the lumen, should not be biopsied because of an increased chance of mucosal </p>
<p>perforation at the time of surgical removal of the entire tumor or enucleation.<o:p></o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </p>
<p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: </p>
<p>Arial">Despite their slow growth and limited potential for malignant deÂ­generation, leiomyomas should be removed </p>
<p>unless there are specific contraindications. The majority can be removed by simple enucleÂ­ation. If during removal </p>
<p>the mucosa is inadvertently entered, the defect can be repaired primarily. After tumor removal, the outer </p>
<p>esophageal wall should be reconstructed by closure of the musÂ­cle layer. The location of the lesion and the extent </p>
<p>of surgery reÂ­quired will dictate the approach. Lesions of the proximal and middle esophagus require a right </p>
<p>thoracotomy, whereas distal esophageal lesions require a left thoracotomy. Videothoracoscopic approaches have been </p>
<p>reported. The mortality rate associated with enucleation is less than 2%, and success in relieving the dysphagia is </p>
<p>near 100%. Large lesions or those involving the gastroesophageal junction may require esophageal </p>
<p>resection.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; </p>
<p>font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span </p>
<p>style="font-size: 10pt; font-family: Arial">Esophageal Cyst<o:p></o:p></span></strong></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Cysts may be </p>
<p>congenital or acquired. Congenital cysts are lined wholly or partly by columnar ciliated epithelium of the </p>
<p>respiraÂ­tory type, by glandular epithelium of the gastric type, by squamous epithelium, or by transitional </p>
<p>epithelium. In some, epithelial linÂ­ing cells may be absent. Confusion over the embryologic origin of congenital </p>
<p>cysts has led to a variety of names, such as enteric, bronchogenic, and mediastinal cysts. Acquired retention cysts </p>
<p>also occur, probably as a result of obstruction of the excretory ducts of the esophageal </p>
<p>glands.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; </p>
<p>font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-</p>
<p>size: 10pt; font-family: Arial">Enteric and bronchogenic cysts are the most common and arise as a result of </p>
<p>developmental abnormalities during the formation and differentiation of the lower respiratory tract, esophagus, and </p>
<p>stomach from the foregut. During its embryologic development, the esophÂ­agus is lined successively with simple </p>
<p>columnar, pseudostratitied ciliated columnar, and finally stratified squamous epithelium. This sequence probably </p>
<p>accounts for the fact that the lining epithelium may be any or a combination of these; the presence of cilia does </p>
<p>not necessarily indicate a respiratory origin.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Cysts, when observed under a </p>
<p>microscope, vary in size from small to very large, and are usually located intramurally in the middle to lower </p>
<p>third of the esophagus. Their symptoms are similar to those of a leiomyoma. The diagnosis similarly depends on </p>
<p>radiographic and endoscopic findings. Surgical excision by enucleation is the preferred treatment. During removal, </p>
<p>a fistulous tract connecting the cysts to the airways should be sought, particularly in patients who have had </p>
<p>repetitive bronchial and lung infections.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/9/feed</wfw:commentRss>
		</item>
		<item>
		<title>Miscellaneous Lesions</title>
		<link>http://medicalmicroscopes.net/WP/archives/8</link>
		<comments>http://medicalmicroscopes.net/WP/archives/8#comments</comments>
		<pubDate>Tue, 17 Jul 2007 03:53:43 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/miscellaneous-lesions/</guid>
		<description><![CDATA[Plummer-Vinson 
Syndrome
 
This uncommon 
clinical syndrome is characterized by dysphagia asÂ­sociated with atrophic oral mucosa, spoon-shaped fingers with 
britÂ­tle nails, and chronic anemia. It characteristically occurs in middle-aged edentulous women. Because iron-
deficiency anemia is a common finding, another name for this condition is sideropenic dysÂ­phagia. The syndrome is 
more common in the Scandinavian counÂ­tries than [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: </p>
<p>justify"><em><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt">Plummer-Vinson </p>
<p>Syndrome<strong><o:p></o:p></strong></span></em></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt">This uncommon </p>
<p>clinical syndrome is characterized by dysphagia asÂ­sociated with atrophic oral mucosa, spoon-shaped fingers with </p>
<p>britÂ­tle nails, and chronic anemia. It characteristically occurs in middle-aged edentulous women. Because iron-</p>
<p>deficiency anemia is a common finding, another name for this condition is sideropenic dysÂ­phagia. The syndrome is </p>
<p>more common in the Scandinavian counÂ­tries than in the <st1:place w:st="on"><st1:country-region w:st="on">United </p>
<p>States</st1:country-region></st1:place>, and its presentation is variable. Not all patients exhibit the classic </p>
<p>syndrome; some lack iron-deficiency anemia and others have the typical clinical stigmata, but lack dysÂ­phagia or </p>
<p>the presence of an esophageal web.</span><span id="more-8"></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt">Clinical </p>
<p>observation with the use of medical microscopes suggests that the esophageal web once thought to be a component of </p>
<p>the syndrome in some patients may actually be a drug-induced lesion, caused by ingestion of ferrous sulfate, a drug </p>
<p>commonly prescribed in cases of iron-deficiency anemia. Ferrous sulfate is known to cause esophageal injury, and a </p>
<p>number of patients may have had a drug-induced esophageal inÂ­jury develop at the site where the web is commonly </p>
<p>observed. Not knowing the cause of the esophageal abnormality, early observers reported the web as part of the </p>
<p>syndrome. Malignant lesions of the oral mucosa, hypopharynx, and esophagus that were studied with the use of </p>
<p>medical microscopes have been noted to occur in up to 100% of patients when followed long-</p>
<p>term.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font</p>
<p>-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt">Videoradiographic studies, as </p>
<p>well as endoscopic findings, have demonstrated a fibrous web just below the cricopharyngeus musÂ­cle as the cause </p>
<p>of dysphagia in these patients. Treatment consists of dilation of the web and iron therapy to correct the </p>
<p>nutritional deficiency.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span </p>
<p>style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></strong></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: Arial; letter-</p>
<p>spacing: 0.1pt">Schatzki&#8217;s ring</span></strong></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt">Schatzki&#8217;s </p>
<p>ring is a thin submucosal circumferential ring in the lower esophagus at the squamocolumnar junction, often </p>
<p>associated with a hiatal hernia. Its significance and pathogenesis are unclear. Templeton first noted the ring, but </p>
<p>Schatzki and Gary defined it as a distinct entity in 1953. Its prevalence varies from 0.2 to 14% in the general </p>
<p>population, depending on the techÂ­nique of diagnosis and the criteria used. Stiennon believed the ring to be a </p>
<p>pleat of mucosa formed by infolding of redundant esophageal mucosa due to shortening of the esophagus. Others </p>
<p>believe the ring to be congenital, and still others suggest it is an early stricture resultÂ­ing from inflammation </p>
<p>of the esophageal mucosa caused by chronic reflux.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: 0.1pt"><o:p> </o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial; letter-spacing: </p>
<p>0.1pt">Schatzki&#8217;s ring is a distinct clinical entity having different symptoms, upper gastrointestinal function </p>
<p>studies, and response to </span><span style="font-size: 10pt; font-family: Arial">treatment when compared with </p>
<p>patients with a hiatal hernia, but without a ring. Twenty-four-hour esophageal pH monitoring has shown that </p>
<p>patients with a Schatzki&#8217;s ring have a lower incidence of reflux than hiatal hernia controls. They also have </p>
<p>better LES funcÂ­tion. This, together with the presence of a ring, as observed using medical microscopes, could </p>
<p>represent a protective mechanism to prevent gastroesophageal reflux.<o:p></o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Symptoms associated </p>
<p>with Schatzki&#8217;s ring are brief episodes of dysphagia during hurried ingestion of solid foods. Its treatment has </p>
<p>varied from dilation alone to dilation with antireflux measures, antireflux procedure alone, incision, and even </p>
<p>excision of the ring. Little is known about the natural progression of Schatzki&#8217;s rings. Using radiologic </p>
<p>techniques, Chen and colleagues showed progresÂ­sive stenosis of rings in 59% of patients, whereas Schatzki found </p>
<p>that the rings decreased in diameter in 29% of patients and remained unchanged in the </p>
<p>rest.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font</p>
<p>-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: </p>
<p>10pt; font-family: Arial">Symptoms in patients with a ring are caused more by the presÂ­ence of the ring than by </p>
<p>gastroesophageal reflux. Most patients with a ring but without proven reflux respond to a single dilation, while </p>
<p>most patients with proven reflux require repeated dilations. It is through these findings that the majority of </p>
<p>Schatzki&#8217;s ring patients without proven reflux have a history of ingestion of drugs known to be damaging to the </p>
<p>esophageal mucosa. Bonavina and associates have suggested drug-induced injury as the cause of stenosis in patients </p>
<p>with a ring, but without a history of reflux. Since rings also occur in patients with proven reflux, it is likely </p>
<p>that gastroesophageal reflux also plays a part. This is supported by the fact that there is less drug ingestion in </p>
<p>the history of these patients. Schatzki&#8217;s ring is probably an acquired lesion that can lead to stenosis from </p>
<p>chemical-induced injury by pill lodgment in the distal esophagus, or from reflux-induced injury to the lower </p>
<p>esophageal mucosa.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-</p>
<p>size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial">The best form of treatment of a symptomatic Schatzki&#8217;s ring in </p>
<p>patients who do not have reflux consists of esophageal dilation for relief of the obstructive symptoms. In patients </p>
<p>with a ring who have proven reflux and a mechanically defective sphincter, an antireflux procedure is necessary to </p>
<p>obtain relief and avoid repeated dilation.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><strong><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></strong></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: Arial">Mallory-</p>
<p>weiss syndrome<o:p></o:p></span></strong></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial">In 1929, Mallory and Weiss described four patients with </p>
<p>acute upper gastrointestinal bleeding who were found at autopsy using medical microscopes to have mucosal tears at </p>
<p>the gastroesophageal junction. This syndrome, characterized by acute upper gastrointestinal bleeding following </p>
<p>repeated vomiting is<sup> </sup>considered to be the cause of up to 15% of all severe upper gastrointestinal </p>
<p>bleeds. The mechanism is similar to spontaneous esophageal perforation: an acute increase in intra-abdominal </p>
<p>pressure against a closed glottis in a patient with a hiatal hernia.<o:p></o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Mallory-Weiss tears </p>
<p>are characterized by arterial bleeding, which may<strong> </strong>be massive. Vomiting is not an obligatory </p>
<p>factor, as there may be other causes of an acute increase in infra-abdominal pressure, such as paroxysmal coughing, </p>
<p>seizures, and retching. The diagnosis requires a high index of suspicion, particularly in the patient who develops </p>
<p>upper gastrointestinal bleeding following prolonged vomiting or retching. The use of upper endoscopy and medical </p>
<p>microscopes confirms the suspicion by identifying one<strong> </strong>or more longitudinal fissures in the mucosa </p>
<p>of the herniated stomach as the source of bleeding.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-</p>
<p>align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">For the majority of patients, the </p>
<p>bleeding will stop spontaneously with no operative management. In addition to blood replacement, the stomach should </p>
<p>be decompressed and antiemetics administered. A distended stomach and continued vomiting aggravate further </p>
<p>bleeding. A Sengstaken-Blakemore tube will not stop the bleeding, as the<strong> </strong>pressure in the balloon </p>
<p>is not sufficient to overcome arterial pressure. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" </p>
<p>style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Surgery is required occasionally to </p>
<p>stop blood loss. The procedure consists of laparotomy and high gastrotomy with over sewing of the linear tear. </p>
<p>Mortality is uncommon and recurrence is rare.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><strong><span style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></strong></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: </p>
<p>Arial">Scleroderma<o:p></o:p></span></strong></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial">Scleroderma is a systemic disease accompanied by </p>
<p>esophageal abÂ­normalities in approximately 80% of patients. In most cases, the disease follows a prolonged course. </p>
<p>Renal involvement occurs in a small percentage of patients and signals a poor prognosis. The onset of the disease </p>
<p>is usually in the third or fourth decade of life, occurring twice as frequently in women as in </p>
<p>men.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-</p>
<p>family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: </p>
<p>10pt; font-family: Arial">Small vessel inflammation, as observed using medical microscopes, appears to be an </p>
<p>initiating event, with subsequent perivascular deposition of normal collagen, which may lead to vascular </p>
<p>compromise. In the gastrointestinal tract, the preÂ­dominant feature is smooth muscle atrophy. Whether the atrophy </p>
<p>in the esophageal musculature is a primary effect or occurs secondary to a neurogenic disorder is unknown. The </p>
<p>results of pharmacologic and hormonal manipulation, with agents that act either indirectly via neural mechanisms or </p>
<p>directly on the muscle, suggest that scleroÂ­derma is a primary neurogenic disorder. Methacholine, which acts </p>
<p>directly on smooth muscle receptors, causes a similar increase in LES pressure in normal controls and in patients </p>
<p>with scleroderma. Edrophonium, a cholinesterase inhibitor that enhances the effect of acetylcholine when given to </p>
<p>patients with scleroderma, causes an increase in LES pressure that is less marked in these patients than in normal </p>
<p>controls, suggesting a neurogenic rather than myogenic etiology. Muscle ischemia due to perivascular compression </p>
<p>has been suggested as a possible mechanism for the motility abnormality in scleroderma. Others have observed that </p>
<p>in the early stage of the disÂ­ease, the manometric abnormalities may be reversed by reserpine, an agent that </p>
<p>depletes catecholamines from the adrenergic system. This suggests that in early scleroderma an adrenergic </p>
<p>overactivity may be present that causes a parasympathetic inhibition, supporting a neurogenic mechanism for the </p>
<p>disease. In advanced disease maniÂ­fested by smooth muscle atrophy and collagen deposition, reserpine no longer </p>
<p>produces this reversal. Consequently, from a clinical perÂ­spective, the patient can be described as having a poor </p>
<p>esophageal pump and a poor valve.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span </p>
<p>style="font-size: 10pt; font-family: Arial"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align: </p>
<p>justify"><span style="font-size: 10pt; font-family: Arial">The diagnosis of scleroderma can be made manometrically </p>
<p>by the observation of normal peristalsis in the proximal striated esophÂ­agus, with absent peristalsis in the </p>
<p>distal smooth muscle portion. The LES pressure is progressively weakened as the disease advances. Because many of </p>
<p>the systemic sequelae of the disÂ­ease may be nondiagnostic, the motility pattern is frequently used as a specific </p>
<p>diagnostic indicator. Gastroesophageal reflux commonly occurs in patients with scleroderma, since they have both </p>
<p>hypotenÂ­sive sphincters and poor esophageal clearance. This combined defect can lead to severe esophagitis and </p>
<p>stricture formation. The typical barium swallow shows a dilated, barium-filled esophagus, stomach, and duodenum, or </p>
<p>a hiatal hernia with distal esophageal stricture and proximal dilatation.<o:p></o:p></span></p>
<p </p>
<p>class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: Arial"><o:p> </p>
<p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; font-family: </p>
<p>Arial">Traditionally, esophageal symptoms have been treated with medications such as H2 blockers, antacids, </p>
<p>elevation of the head of the bed, and multiple diÂ­lations for strictures, with generally unsatisfactory results. </p>
<p>The deÂ­gree of esophagitis is usually severe and leads to marked esophageal shortening. Consequently a Collis </p>
<p>gastroplasty in combination with a Belsey antireflux repair is the usual procedure for the surgical management of </p>
<p>this problem. Surgery reduces esophageal acid exÂ­posure, but does not return it to normal because of the poor </p>
<p>clearance function of the body of the esophagus. Only 50% of the patients have a good-to-excellent result. If the </p>
<p>esophagitis is severe, or there has been a previous failed antireflux procedure and the disease is associated with </p>
<p>delayed gastric emptying, a gastric resection with Roux-en-Y esophagojejunostomy and a Hunt-Lawrence pouch has </p>
<p>proved the best option.<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/8/feed</wfw:commentRss>
		</item>
		<item>
		<title>Urine Specimen Collection</title>
		<link>http://medicalmicroscopes.net/WP/archives/7</link>
		<comments>http://medicalmicroscopes.net/WP/archives/7#comments</comments>
		<pubDate>Wed, 27 Jun 2007 23:53:17 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/urine-specimen-collection/</guid>
		<description><![CDATA[Collection and preservation of urine for analytical testing 
must follow a carefully prescribed procedure to ensure valid results. Laboratory testing of urine generally falls 
under three categories, example, chemical, bacteriologic, and microscopic examination. There are also three kinds 
of collection for urine specimens, first random, second timed, and third 24-hour total volume. Random specimens may [...]]]></description>
			<content:encoded><![CDATA[<p>Collection and preservation of urine for analytical testing </p>
<p>must follow a carefully prescribed procedure to ensure valid results. Laboratory testing of urine generally falls </p>
<p>under three categories, example, chemical, bacteriologic, and microscopic examination. There are also three kinds </p>
<p>of collection for urine specimens, first random, second timed, and third 24-hour total volume. Random specimens may </p>
<p>be collected any time, but a first morning voided aliquot is optimal for constituent concentration. Laboratory </p>
<p>results from a random urine collection are expressed per unit volume if the result is a quantitative analysis. </p>
<p>Result reporting of a random collection is expressed as positive or negative, indicating the presence or absence of </p>
<p>a particular constituent, such as glucose. Random urine specimens should be collected in a chemically clean </p>
<p>receptacle, either glass or plastic. A clean-catch midstream specimen is most desirable for bacteriologic </p>
<p>examinations using medical microscopes. <span id="more-7"></span>The vessel is tightly sealed, labeled with the patient&#8217;s name </p>
<p>and date of collection, and submitted for analysis. A first morning urine specimen is generally the most </p>
<p>concentrated and considered a better specimen for evaluation. Timed specimens are obtained at designated intervals, </p>
<p>starting from time zero, and are noted on each subsequent container time of collection. Urine specimens for a 24-</p>
<p>hour total volume collection are most difficult to obtain and require cooperation from the patient. Incomplete </p>
<p>collection is the major problem.</p>
<p>In some instances, over collection occurs. Because in-hospital collection </p>
<p>is usually under the supervision of the nursing staff, it is more reliable than outpatient collections. Collection </p>
<p>of urine specimens from pediatric patients requires special attention to avoid contamination from the stool. One </p>
<p>can avoid problems by giving patients complete written and verbal instructions with a warning that the test can be </p>
<p>invalidated by incorrect collection technique. If specimen is to be collected on an outpatient basis, exercise care </p>
<p>and instruct patient&#8217;s parents to keep the specimen out of the reach of children, especially if concentrated acid </p>
<p>is used as a preservative. An unbreakable, 4 L approximately plastic, chemically clean container with the correct </p>
<p>preservative already added is preferred. One should remind the patient to discard the first morning specimen, </p>
<p>record the time, and collect every subsequent voiding for the next 24 hours, with the last to be 24 hours after </p>
<p>timing commenced. Over collection occurs if the first morning specimen is included in this routine. Measure the </p>
<p>total volume collected, record the information on the request form, thoroughly mix the entire 24-hour collection, </p>
<p>and submit for analysis. A 40-mL aliquot is adequate for this purpose. Completeness of collection is difficult to </p>
<p>determine.</p>
<p>If results appear clinically invalid when examined under a medical microscope, this is cause for </p>
<p>suspicion. Because creatinine excretion is based on muscle mass, and because a patient&#8217;s muscle mass is relatively </p>
<p>constant, creatinine excretion is also reasonably constant. Therefore, one should measure creatinine on several 24</p>
<p>-hour collections and keep this as part of the patient&#8217;s record. Another approach is to express results relative </p>
<p>to the concentration of creatinine when collecting a specimen other than a 24-hour one. One and two-hour timed </p>
<p>collection specimens may suffice in some instances.</p>
<p><em>SPECIAL URINE COLLECTION </p>
<p>TECHNIQUES</em></p>
<p>Catheterization of the bladder may cause infection but is necessary in some patients. </p>
<p>Catheterization also is used for urine collection when patients are unable to void or control micturition. </p>
<p>Suprapubic aspiration is performed with a syringe and needle above the symphysis pubis, through the abdominal wall, </p>
<p>into a full bladder. This method is used to obtain otherwise problematic anaerobic cultures. Ureteral catheters are </p>
<p>inserted via a cystoscope into the ureter. Bladder urine is collected first, followed by a bladder washing. </p>
<p>Ureteral urine specimens are useful in differentiating bladder from kidney infection or for differential ureteral </p>
<p>analysis using medical microscopes, and may be obtained separately from each kidney pelvis labeled left and right. </p>
<p>First morning urine samples for cytologic examination are optimal.</p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/7/feed</wfw:commentRss>
		</item>
		<item>
		<title>Indwelling Lines and Catheter Access</title>
		<link>http://medicalmicroscopes.net/WP/archives/6</link>
		<comments>http://medicalmicroscopes.net/WP/archives/6#comments</comments>
		<pubDate>Wed, 27 Jun 2007 23:51:52 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/indwelling-lines-and-catheter-access/</guid>
		<description><![CDATA[Indwelling catheters such as central venous lines provide 
ready access to the patient circulation, eliminating multiple phlebotomies, and are especially useful in critical 
care and surgical situations. Arterial catheters most often are placed in the radial artery. Indwelling catheters 
are surgically inserted in the cephalic vein or internal jugular, subclavian, or femoral veins and positioned. [...]]]></description>
			<content:encoded><![CDATA[<p>Indwelling catheters such as central venous lines provide </p>
<p>ready access to the patient circulation, eliminating multiple phlebotomies, and are especially useful in critical </p>
<p>care and surgical situations. Arterial catheters most often are placed in the radial artery. Indwelling catheters </p>
<p>are surgically inserted in the cephalic vein or internal jugular, subclavian, or femoral veins and positioned. They </p>
<p>are especially useful in selected patients for drawing venous blood, administering drugs or blood products, and </p>
<p>providing total parenteral nutrition. Continuous, real-time intra-arterial monitoring of blood gases and acid-base </p>
<p>status using fiberoptic channels containing fluorescent and absorbent chemical analyses has been used </p>
<p>successfully.</p>
<p><span id="more-6"></span>Placement of indwelling catheters, although not a routine laboratory function, is </p>
<p>of primary concern to the laboratorian blood specimens drawn from catheters may be contaminated with whatever was </p>
<p>administered or infused via the catheter. The solution, usually heparin used to maintain patency of the vein must </p>
<p>also be cleared. Sufficient blood minimum of 2 to 3 mL must be withdrawn to clear the line so laboratory data are </p>
<p>reliable. To obtain a blood specimen from the indwelling catheter, first draw 6 mL of intravenous fluid from the </p>
<p>line and discard. In a separate syringe, withdraw the amount of blood required for requested laboratory procedures. </p>
<p>Follow strict aseptic technique to avoid site or catheter contamination or both. Coagulation measurements </p>
<p>prothrombin time, activated partial thromboplastin time, and thrombin time are extremely sensitive to heparin </p>
<p>interference, so that even larger volumes of presample blood must be withdrawn before the laboratory results are </p>
<p>acceptable. The appropriate volume to be discarded should be established by each laboratory when performing </p>
<p>prothrombin times PT and activated partial thromboplastin times APTT, a minimum of 5.3 mL discard volume should be </p>
<p>used. The laboratory is sometimes asked to perform blood culture studies, using medical microscopes, on blood drawn </p>
<p>from indwelling catheters. This procedure is not recommended since, when viewed under a medical microscope, the </p>
<p>organisms that grow on the walls of the catheter can contaminate the blood specimen.</p>
<p>SPECIMEN </p>
<p>INTERFERENCES</p>
<p>The collection of specimens depends on proper identification of the patient, the appropriate </p>
<p>collecting method to procure the specimen, and the correct collection tubes. Timed collections must be verified to </p>
<p>ensure accuracy in generating laboratory data that will be used in the diagnosis or management of a patient. The </p>
<p>site of collection is generally not critical except for glucose tolerance test, in which it has been reported that </p>
<p>capillary glucose is 10 to 30 percent higher than venous blood glucose. Additionally, blood specimens collected </p>
<p>from an extremity with any type of catheter delivering parenteral solutions can generate artefactual results. If </p>
<p>this type of collection cannot be avoided, the venipuncture must be performed distal to the intravenous needle </p>
<p>site, with the tourniquet between the two. Blood-drawing equipment must be void of any residual detergents, </p>
<p>plasticizers, or other material that may interfere with laboratory determinations. Examples include specimens for </p>
<p>lead analysis, which must be collected in acid-washed, lead-free containers, and contamination from tissue </p>
<p>thromboplastin that may interfere with specific coagulation assays if a double-syringe technique first 5 mL of </p>
<p>blood is discarded is not used.</p>
<p>Lysis of red blood cells during the collection process or after phlebotomy, </p>
<p>before analysis is performed using medical microscopes, can contaminate the serum or plasma and alter results in </p>
<p>vitro hemolysis. Overzealous mixing of blood in collection tubes, residual alcohol left when cleansing skin, </p>
<p>prolonged exposure of tubes to heat or extreme cold freezing, and inadequate removal of red cells during </p>
<p>centrifugation may cause hemolysis. Even small amounts of lysed erythrocytes may have a significant impact on blood </p>
<p>plasma and serum analyte concentrations. In vitro hemolysis results may show increased levels of serum acid </p>
<p>phosphatase, zinc, magnesium, albumin, potassium, bilirubin spectrophometrically determined, and CK. Thrombolysis </p>
<p>can result in elevated serum potassium, magnesium, acid phosphatase, and aldolase. Granulocytosis releases </p>
<p>muramidase lysozyme, phosphohexose isomerase, arginase, glucose-6-phosphatase G6PD, and glutamate dehydrogenase. </p>
<p>Hemolysis may alter spectrophometric readings, such as those used in coagulation studies or hemoglobin </p>
<p>evaluations.</p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/6/feed</wfw:commentRss>
		</item>
		<item>
		<title>Body Fluids</title>
		<link>http://medicalmicroscopes.net/WP/archives/5</link>
		<comments>http://medicalmicroscopes.net/WP/archives/5#comments</comments>
		<pubDate>Wed, 27 Jun 2007 23:50:57 +0000</pubDate>
		<dc:creator></dc:creator>
		
		<guid isPermaLink="false">http://medicalmicroscopes.net/body-fluids/</guid>
		<description><![CDATA[CEREBROSPINAL FLUID 
Lumbar punctures 
LPs are performed to collect cerebrospinal fluid CSF that may be evaluated in the laboratory to establish a 
diagnosis of infection bacterial, fungal, mycobacterial, or amebic meningitis, malignancy, subarachnoid hemorrhage, 
multiple sclerosis, or demyelinating disorders using medical microscopes. A serious complication of an LP is 
cerebellar tonsillar herniation in patients with [...]]]></description>
			<content:encoded><![CDATA[<p><strong>CEREBROSPINAL FLUID </strong></p>
<p>Lumbar punctures </p>
<p>LPs are performed to collect cerebrospinal fluid CSF that may be evaluated in the laboratory to establish a </p>
<p>diagnosis of infection bacterial, fungal, mycobacterial, or amebic meningitis, malignancy, subarachnoid hemorrhage, </p>
<p>multiple sclerosis, or demyelinating disorders using medical microscopes. A serious complication of an LP is </p>
<p>cerebellar tonsillar herniation in patients with elevated intracranial pressure and should be avoided unless CSF </p>
<p>findings are expected to improve treatment or outcome. Patients with spinal cord tumors with paresis may progress </p>
<p>to paralysis following LP. <span id="more-5"></span>To avoid introduction of infection, patients with sepsis in the lumbar region </p>
<p>skin infection, cellulitis, or epidural abscess should not have an LP performed to avoid introduction of infection. </p>
<p>Other complications of lumbar puncture include asphyxiation in infants due to hyper extending the head forward, </p>
<p>thus occluding the trachea, paresthesia, headache, and rarely, hematomas.<br />
Before collection of CSF begins, the </p>
<p>pressure, measured by allowing fluid to rise in a sterile, graduated manometer, should be between 90 and 180 mmHg. </p>
<p>Breath holding, abdominal compression, congestive heart failure, inflammation of the meninges, obstruction of </p>
<p>intracranial venous sinuses, mass lesions, and cerebral edema may cause the pressure to be elevated above 180 mm </p>
<p>Hg. Initially, only 1 to 2 mL of CSF should be removed. A marked decrease in pressure following this procedure </p>
<p>suggests cerebellax herniation or spinal cord compression, thus no additional CSF should be collected. Patients </p>
<p>with partial or complete spinal block may have low pressure less than 80 mm Hg, falling to zero after removal of </p>
<p>only 1 mL. Again, no additional fluid should be removed. If pressure is normal and does not fall after several </p>
<p>milliliters are removed, additional fluid may be taken. Three aliquots are generally collected in separate, sterile </p>
<p>tubes labeled appropriately with name, date, and sequential tube collection number aid distributed for chemical and </p>
<p>immunologic studies, microbiologic studies second, and cell count and differential third. Closing pressure of 40 to </p>
<p>90 mm Hg is common after 10 to 20 mL of CSF has been removed.</p>
<p><strong>SYNOVIAL FLUID </p>
<p></strong></p>
<p>Synovial fluid is produced by dialysis of plasma across the synovial membrane and secretion of a </p>
<p>hyaluronate-protein complex. This fluid is collected using careful, aseptic technique, avoiding aspiration from </p>
<p>patients with bacteremia or extra-articular soft tissue infection. Collection of synovial fluid arthrocentesis </p>
<p>should be performed after six hours of fasting into a syringe containing about 25 units of heparin per milliliter </p>
<p>of synovial fluid collected. Generally, less than 2.0 mL of fluid is collected unless an effusion is present and </p>
<p>therapeutic collection is continued. Using additional syringes, larger amounts may be collected when appropriate </p>
<p>for microbiologic and other studies using various types of microscopes like a medical </p>
<p>microscope.</p>
<p><strong>PLEURAL FLUID, PERICARDIAL FLUID, AND PERITONEAL FLUID </strong></p>
<p>The lubricating </p>
<p>fluids found between potential spaces of pleura, from the pericardial sac, or from the peritoneum, may accumulate </p>
<p>excessively. Thoracentesis is a surgical procedure that is performed to drain accumulated fluids effusions from the </p>
<p>thoracic cavity and is helpful in the diagnosis of inflammation or neoplastic diseases in the lung or pleura. </p>
<p>Likewise, pericardiocentesis and peritoneocentesis refer to the collection of fluid from the pericardium and the </p>
<p>peritoneal cavities, respectively.</p>
<p>The patient, sitting in an upright position, with arms and head extended </p>
<p>on an overbed table, is prepared with a local anesthetic after appropriate cleansing of the site. A 50-mL syringe </p>
<p>is fitted with a stopcock and rubber tubing to assist in the aseptic collection process. Specimens are obtained for </p>
<p>chemical, microbiological, and cylologie examination and measurements using medical microscopes and are transferred </p>
<p>to collecting tubes with appropriate additives. For most chemical evaluations, no additive is used and specimen is </p>
<p>allowed to clot. Bacteriologic and cytologic specimens may be collected in EDTA or sterile sodium heparin without </p>
<p>preservatives. Special studies for Mycobacterium, anaerobie bacteria, or viruses may require special handling </p>
<p>procedures, which are planned and reviewed prior to collection.</p>
]]></content:encoded>
			<wfw:commentRss>http://medicalmicroscopes.net/WP/archives/5/feed</wfw:commentRss>
		</item>
	</channel>
</rss>

